Skip to content
value.today

OptimizeRx Corporation vs Simulations Plus, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Simulations Plus, Inc. is the larger company by market value: $371 M against $165 M for OptimizeRx Corporation, 2.2 times as much (market caps of Oct 20, 2026 for OptimizeRx Corporation and Aug 1, 2026 for Simulations Plus, Inc.). Simulations Plus, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
  • OptimizeRx Corporation had more revenue: $109 M in the year to December 2025 against $79 M for Simulations Plus, Inc. in the year to August 2025.
  • OptimizeRx Corporation made a net profit of $5 M, while Simulations Plus, Inc. made a net loss of $65 M.
  • OptimizeRx Corporation keeps more of each dollar of sales: a net margin of 4.7% against -81.7% for Simulations Plus, Inc.
  • OptimizeRx Corporation's revenue grew faster in its latest fiscal year: +18.8% against +13.1% for Simulations Plus, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

01633274906532020202120222023202420252026OptimizeRx Corporation 114Simulations Plus, Inc. 74

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025OptimizeRx Corporation $0BSimulations Plus, Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureOptimizeRx Corporation
OPRX · #16,963 in the world
Simulations Plus, Inc.
SLP
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryHealthcare Information ServicesHealthcare Information Services
Founded20061996
Size
Market cap$165 M$371 M*
Revenue$109 M$79 M
Net income$5 M▲ best$-65 M
Employees82—
Valuation
P/E ratio35.9×—
Price to sales1.7×—
Price to book1.3×—
Free cash flow yield11.3%—
Profitability
Gross margin67.3%▲ best58.4%
Operating margin10.7%▲ best-89.3%
Net margin4.7%▲ best-81.7%
Return on equity4.2%▲ best-42.1%
Return on invested capital6.4%—
Growth
Revenue growth18.8%▲ best13.1%
Revenue growth, 3 years a year20.6%▲ best13.7%
Financial strength
Debt to equity0.2×—
Net debt to EBITDA0.2×—
Cash
Free cash flow margin17.1%22.0%▲ best
Strength scores
Piotroski F-score8 of 9—
Altman Z-score zonegrey—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Aug 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, OptimizeRx Corporation or Simulations Plus, Inc.?

Simulations Plus, Inc. is the larger company by market value: $371 M against $165 M for OptimizeRx Corporation, 2.2 times as much (market caps of Oct 20, 2026 for OptimizeRx Corporation and Aug 1, 2026 for Simulations Plus, Inc.). Simulations Plus, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, OptimizeRx Corporation or Simulations Plus, Inc.?

OptimizeRx Corporation had more revenue: $109 M in the year to December 2025 against $79 M for Simulations Plus, Inc. in the year to August 2025. OptimizeRx Corporation made a net profit of $5 M, while Simulations Plus, Inc. made a net loss of $65 M.

Which is more profitable, OptimizeRx Corporation or Simulations Plus, Inc.?

OptimizeRx Corporation keeps more of each dollar of sales: a net margin of 4.7% against -81.7% for Simulations Plus, Inc.

Which is growing faster, OptimizeRx Corporation or Simulations Plus, Inc.?

OptimizeRx Corporation's revenue grew faster in its latest fiscal year: +18.8% against +13.1% for Simulations Plus, Inc.

Sources#

Every figure on this page comes from these, with the date shown next to it.